Early signs that patient's own bone-marrow stem cells could treat multi-drug resistant tuberculosis
Findings of a preliminary study published in The Lancet Respiratory Medicine suggest that a patient's own bone-marrow stromal (stem) cells could be used to treat multidrug-resistant and extensively-drug tuberculosis.
Jan 8, 2014
0
0